Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Telomerase gene mutations are associated with cirrhosis formation.
Hartmann D, Srivastava U, Thaler M, Kleinhans KN, N'kontchou G, Scheffold A, Bauer K, Kratzer RF, Kloos N, Katz SF, Song Z, Begus-Nahrmann Y, Kleger A, von Figura G, Strnad P, Lechel A, Günes C, Potthoff A, Deterding K, Wedemeyer H, Ju Z, Song G, Xiao F, Gillen S, Schrezenmeier H, Mertens T, Ziol M, Friess H, Jarek M, Manns MP, Beaugrand M, Rudolph KL. Hartmann D, et al. Among authors: deterding k. Hepatology. 2011 May;53(5):1608-17. doi: 10.1002/hep.24217. Hepatology. 2011. PMID: 21520174
Antiviral Therapy of Chronic Hepatitis D Virus Infection - Addendum to the S3 Guideline "Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection" of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS).
Sandmann L, Berg T, Deterding K, Fischer N, Hinrichsen H, Petersen J, Tacke F, Cornberg M; Collaborators. Sandmann L, et al. Among authors: deterding k. Z Gastroenterol. 2023 Dec;61(12):e715-e732. doi: 10.1055/a-2181-3345. Epub 2023 Dec 11. Z Gastroenterol. 2023. PMID: 38081178 No abstract available.
Addendum „Antivirale Therapie der chronischen Hepatitis-D-Virusinfektion“ zur S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).
Sandmann L, Berg T, Deterding K, Fischer N, Hinrichsen H, Petersen J, Tacke F, Cornberg M; Collaborators. Sandmann L, et al. Among authors: deterding k. Z Gastroenterol. 2023 Dec;61(12):1635-1653. doi: 10.1055/a-2181-3046. Epub 2023 Dec 11. Z Gastroenterol. 2023. PMID: 38081179 Free article. German. No abstract available.
Present and future therapy for hepatitis C virus.
Cornberg M, Deterding K, Manns MP. Cornberg M, et al. Among authors: deterding k. Expert Rev Anti Infect Ther. 2006 Oct;4(5):781-93. doi: 10.1586/14787210.4.5.781. Expert Rev Anti Infect Ther. 2006. PMID: 17140355 Review.
Steroid treatment for severe acute cryptogenic hepatitis.
Potthoff A, Deterding K, Trautwein C, Flemming P, Strassburg CP, Manns MP, Wedemeyer H, Bahr MJ. Potthoff A, et al. Among authors: deterding k. Z Gastroenterol. 2007 Jan;45(1):15-9. doi: 10.1055/s-2006-927280. Z Gastroenterol. 2007. PMID: 17236116
Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.
Potthoff A, Deterding K, Trautwein C, Rifai K, Manns MP, Wedemeyer H. Potthoff A, et al. Among authors: deterding k. Eur J Gastroenterol Hepatol. 2007 Oct;19(10):906-9. doi: 10.1097/MEG.0b013e3282094160. Eur J Gastroenterol Hepatol. 2007. PMID: 17873617
Clearance of chronic HCV infection during acute delta hepatitis.
Deterding K, Pothakamuri SV, Schlaphoff V, Hadem J, Metzler F, Bahr MJ, Manns MP, Cornberg M, Wedemeyer H. Deterding K, et al. Infection. 2009 Apr;37(2):159-62. doi: 10.1007/s15010-007-7204-7. Epub 2007 Dec 14. Infection. 2009. PMID: 18084714
105 results